TRIKAFTA may give patients with cystic fibrosis hope for healthy pregnancies. Learn about the landmark clinical trial to analyze its safety from pregnancy through two years after delivery.
More men are dying from COVID-19, and testosterone may be part of the explanation. In this MedBlog, Raksha Jain, M.D., who researches sex hormones and their affect on infection, discusses the underlying causes of men's risk factors.
A new 3-drug combo drug for cystic fibrosis has been approved by the FDA. TRIKAFTA offers life-changing treatment potential for approximately 90% of patients with the disease. In this MedBlog, discover who is eligible and how the drug works. Learn more.
Traditionally, patients with cystic fibrosis have been treated with inhaled medications that could affect the lungs with limited systemic effects. However, a relatively new set of drugs, CFTR modulators, offer an oral alternative with the potential to slow the progression of the disease for up to 90 percent of patients.
